Lv44
540 积分 2023-11-16 加入
KRAS mutation status critically determines the clinical outcome of patients with KMT2A-rearranged acute myeloid leukemia
14天前
已完结
Contemporary outcomes in IDH‐mutated acute myeloid leukemia: The impact of co‐occurring NPM1 mutations and venetoclax‐based treatment
14天前
已完结
Association of FLT3-ITD and NPM1 mutations with outcomes of allogeneic hematopoietic cell transplantation in acute myeloid leukemia
24天前
已完结
CAR T or NK cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant
1个月前
已完结
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in active disease: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
2个月前
已完结
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in active disease: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
3个月前
已完结
Real‐World Outcomes of Relapsed/Refractory Core‐Binding Factor Acute Myeloid Leukemia: A COMMAND Registry Study
3个月前
已完结
Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML
3个月前
已完结
Advances in acute myeloid leukemia
3个月前
已完结
Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
1年前
已完结
皖公网安备34019202002308
